Pharmacotherapy to Support PCI: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{PCI}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | |||
*[[Antiplatelet Therapy to Support PCI]] | *[[Antiplatelet Therapy to Support PCI]] | ||
*[[Antithrombin Therapy to Support PCI]] | *[[Antithrombin Therapy to Support PCI]] | ||
*[[Statin therapy to support PCI]] | *[[Statin therapy to support PCI]] | ||
==References== | |||
{{reflist|2}} | |||
{{WH}} | |||
{{WS}} | |||
{{Electrocardiography}} | {{Electrocardiography}} | ||
Line 13: | Line 18: | ||
[[Category:Electrophysiology]] | [[Category:Electrophysiology]] | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
Revision as of 13:38, 29 October 2012
Percutaneous coronary intervention Microchapters |
PCI Complications |
---|
PCI in Specific Patients |
PCI in Specific Lesion Types |
Pharmacotherapy to Support PCI On the Web |
American Roentgen Ray Society Images of Pharmacotherapy to Support PCI |
Directions to Hospitals Treating Percutaneous coronary intervention |
Risk calculators and risk factors for Pharmacotherapy to Support PCI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
- Antiplatelet Therapy to Support PCI
- Antithrombin Therapy to Support PCI
- Statin therapy to support PCI